Small bowel bleeding (SBB) accounts for up to 10% of all gastrointestinal bleeding
(GIB) episodes. Despite balloon assisted enteroscopy (BAE) directed therapy, the long
term rebleeding rate can approach 40%. There is a paucity of data on the outcomes
of second BAE in SBB. The study aims were to: 1) determine the diagnostic yield (DY)
and therapeutic yield (TY) of second BAE in SBB and 2) assess the clinical and endoscopic
predictors of a positive second BAE.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
